ADC Therapeutics SA
ADCT3.120USD
-0.160-4.88%
Close 07/28, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 07/29, 09:30 (ET)
309.44MMarket Cap
LossP/E TTM
ADC Therapeutics SA
3.120
-0.160-4.88%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Total revenue
27.59%23.03M
0.71%16.91M
27.40%18.46M
-9.71%17.41M
-4.94%18.05M
--16.79M
-81.01%14.49M
11.52%19.28M
-59.16%18.99M
480.52%76.32M
359.87%17.29M
--46.50M
--17.01M
--13.15M
--3.76M
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--1.96M
--378.00K
Revenue
27.59%23.03M
0.71%16.91M
27.40%18.46M
-9.71%17.41M
-4.94%18.05M
--16.79M
-81.01%14.49M
11.52%19.28M
-59.16%18.99M
480.52%76.32M
359.87%17.29M
--46.50M
--17.01M
--13.15M
--3.76M
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--1.96M
--378.00K
Cost of revenue
-17.89%2.06M
12.75%1.37M
309.13%851.00K
7.51%1.22M
465.32%2.51M
--1.22M
-60.61%208.00K
180.20%1.13M
-16.07%444.00K
5.18%528.00K
233.88%404.00K
--529.00K
--770.00K
--502.00K
--121.00K
----
----
----
----
----
----
----
----
----
Operating expenses
-0.33%51.50M
-13.07%49.35M
6.69%54.03M
-21.18%46.45M
-25.85%51.67M
--56.77M
-35.63%50.64M
-30.18%58.93M
-20.12%69.67M
10.43%78.67M
4.21%84.40M
23.43%87.22M
3.64%80.84M
35.87%71.24M
80.19%80.99M
61.02%70.67M
118.29%78.00M
59.63%52.43M
73.89%44.95M
60.66%43.88M
--35.73M
--32.84M
--25.85M
--27.32M
R&D expenses
12.41%28.93M
-10.65%27.10M
20.02%32.50M
-22.48%24.30M
-32.99%25.73M
--30.33M
-34.67%27.08M
-34.52%31.34M
-21.73%38.41M
12.73%41.45M
4.22%47.86M
26.31%49.07M
-10.99%43.22M
14.35%36.77M
76.98%45.93M
9.82%38.85M
59.58%48.55M
5.28%32.16M
19.26%25.95M
42.57%35.38M
--30.42M
--30.54M
--21.76M
--24.81M
Depreciation, depletion, and amortization
-4.98%801.00K
-6.38%793.00K
-9.38%802.00K
3.20%838.00K
21.47%843.00K
--847.00K
54.72%885.00K
38.57%812.00K
16.84%694.00K
-13.07%572.00K
-7.72%586.00K
2.77%594.00K
-1.68%759.00K
34.56%658.00K
--635.00K
--578.00K
55.33%772.00K
37.36%489.00K
----
----
--497.00K
--356.00K
----
----
Operating profit
15.32%-28.46M
18.87%-32.44M
1.62%-35.56M
26.75%-29.04M
33.68%-33.61M
---39.98M
-1440.22%-36.15M
40.92%-39.65M
-24.45%-50.68M
95.96%-2.35M
13.10%-67.11M
42.37%-40.73M
18.17%-63.83M
-10.80%-58.09M
-71.83%-77.23M
-61.02%-70.67M
-118.29%-78.00M
-59.63%-52.43M
-88.17%-44.95M
-62.92%-43.88M
---35.73M
---32.84M
---23.89M
---26.94M
Net non-operating interest income (expenses)
Non-operating interest income
-30.33%2.05M
-19.97%2.63M
27.19%3.44M
37.14%3.25M
27.95%2.95M
--3.29M
890.11%2.70M
14725.00%2.37M
-87.42%2.30M
1606.25%273.00K
6.67%16.00K
121953.33%18.31M
-80.00%20.00K
-90.18%16.00K
-92.31%15.00K
-95.99%15.00K
-54.13%100.00K
-77.64%163.00K
-70.41%195.00K
-42.19%374.00K
--218.00K
--729.00K
--659.00K
--647.00K
Non-operating interest expense
-2.13%12.23M
-7.67%11.92M
2.35%13.12M
22.99%12.68M
19.96%12.50M
--12.91M
12.86%12.82M
17.13%10.31M
13.02%10.42M
166.26%11.36M
244.46%8.80M
360.85%9.22M
365.07%9.52M
119.85%4.26M
184.84%2.56M
4661.90%2.00M
3913.73%2.05M
5962.50%1.94M
2391.67%897.00K
13.51%42.00K
--51.00K
--32.00K
--36.00K
--37.00K
Gains from sale of securities
---90.00K
90.74%-5.00K
-46.15%21.00K
-493.33%-59.00K
----
---54.00K
169.64%39.00K
-93.27%15.00K
-164.20%-52.00K
-700.00%-56.00K
192.15%223.00K
-79.44%81.00K
74.04%-95.00K
94.96%-7.00K
-142.00%-242.00K
1258.62%394.00K
-311.56%-366.00K
61.39%-139.00K
-1100.00%-100.00K
137.18%29.00K
--173.00K
---360.00K
--10.00K
---78.00K
Return on equity
----
----
----
----
----
----
----
----
45.52%-1.36M
3.62%-2.13M
-63.99%-1.92M
-374.76%-2.50M
-111.35%-2.77M
---2.21M
---1.17M
---527.00K
--24.37M
----
----
----
----
----
----
----
Special income (expenses)
----
101.43%4.00K
707.14%1.13M
11050.00%2.23M
----
---279.00K
100.39%140.00K
-99.84%20.00K
-97.64%383.00K
-439.05%-35.83M
38.07%12.16M
-23.40%16.22M
109350.00%19.66M
-119.62%-6.65M
111.11%8.80M
--21.17M
---18.00K
--33.87M
---79.26M
--0.00
----
----
----
----
Other non-operating income (expenses)
100.46%12.00K
6.34%10.45M
-52.86%206.00K
104.86%263.00K
---2.59M
--9.82M
--437.00K
---5.42M
----
----
----
----
-100.00%0.00
-240.00%-203.00K
89.73%-148.00K
----
-27.48%161.00K
-89.88%145.00K
---1.44M
--148.00K
--222.00K
--1.43M
----
----
Income before tax
15.38%-38.72M
22.02%-31.28M
3.86%-43.89M
31.97%-36.03M
23.52%-45.76M
---40.11M
11.27%-45.65M
19.05%-52.97M
-235.38%-59.83M
27.96%-51.44M
9.78%-65.44M
65.44%-17.84M
-1.30%-56.53M
-251.21%-71.40M
42.64%-72.53M
-18.99%-51.61M
-58.67%-55.80M
34.57%-20.33M
-443.79%-126.45M
-64.27%-43.38M
---35.17M
---31.07M
---23.25M
---26.41M
Income tax
-171.17%-116.00K
-101.28%-550.00K
46.20%-177.00K
98.21%-86.00K
140.55%163.00K
--42.94M
60.50%-329.00K
-353.63%-4.81M
65.87%-402.00K
-674.48%-833.00K
-2687.80%-1.06M
-1254.02%-1.18M
-17676.98%-22.15M
4933.33%145.00K
-60.58%41.00K
-187.00%-87.00K
9.57%126.00K
-101.12%-3.00K
10.64%104.00K
-4.76%100.00K
--115.00K
--268.00K
--94.00K
--105.00K
Equity earnings after tax
----
100.00%0.00
81.55%-260.00K
22.16%-597.00K
---687.00K
---1.99M
---1.41M
---767.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
15.93%-38.60M
63.00%-30.73M
3.55%-43.71M
25.35%-35.95M
22.73%-45.92M
---83.04M
10.45%-45.32M
25.19%-48.16M
-256.68%-59.43M
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
-58.51%-55.93M
35.14%-20.33M
-442.05%-126.56M
-64.00%-43.48M
---35.28M
---31.34M
---23.35M
---26.51M
Net income from continuous operations
17.17%-38.60M
63.86%-30.73M
5.90%-43.97M
25.30%-36.54M
21.57%-46.61M
---85.03M
7.67%-46.73M
24.00%-48.92M
-256.68%-59.43M
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
-58.51%-55.93M
35.14%-20.33M
-442.05%-126.56M
-64.00%-43.48M
---35.28M
---31.34M
---23.35M
---26.51M
Net income attributable to controlling interests
17.17%-38.60M
63.86%-30.73M
5.90%-43.97M
25.30%-36.54M
21.57%-46.61M
---85.03M
7.67%-46.73M
24.00%-48.92M
-256.68%-59.43M
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
-58.51%-55.93M
35.14%-20.33M
-442.05%-126.56M
-64.00%-43.48M
---35.28M
---31.34M
---23.35M
---26.51M
Net income attributable to common shareholders
17.17%-38.60M
63.86%-30.73M
5.90%-43.97M
25.30%-36.54M
21.57%-46.61M
---85.03M
7.67%-46.73M
24.00%-48.92M
-256.68%-59.43M
29.27%-50.61M
11.29%-64.37M
67.67%-16.66M
38.53%-34.38M
-251.97%-71.55M
42.66%-72.57M
-18.52%-51.53M
-58.51%-55.93M
35.14%-20.33M
-442.05%-126.56M
-64.00%-43.48M
---35.28M
---31.34M
---23.35M
---26.51M
Basic earnings per share
36.22%-0.36
71.80%-0.29
26.16%-0.42
36.40%-0.38
23.23%-0.56
---1.03
12.03%-0.57
28.26%-0.60
-239.09%-0.74
30.74%-0.65
11.51%-0.84
67.71%-0.22
38.59%-0.45
-251.87%-0.93
47.15%-0.95
-9.24%-0.67
-79.94%-0.73
38.07%-0.26
-461.48%-1.79
-69.88%-0.61
---0.41
---0.43
---0.32
---0.36
Diluted earnings per share
36.22%-0.36
71.80%-0.29
26.16%-0.42
36.40%-0.38
23.23%-0.56
---1.03
12.03%-0.57
28.26%-0.60
-239.09%-0.74
30.74%-0.65
11.51%-0.84
67.71%-0.22
38.59%-0.45
-251.87%-0.93
47.15%-0.95
-9.24%-0.67
-79.94%-0.73
38.07%-0.26
-461.48%-1.79
-69.88%-0.61
---0.41
---0.43
---0.32
---0.36
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
